UAB researchers have launched DiaClue, a free web-based tool that helps clinicians classify diabetes into five subtypes, ...
For all the hype about data centers in space, there just aren’t very many GPUs up there. As that starts to change, the near-term business of orbital compute is starting to take shape. The largest ...
Google's TurboQuant algorithm significantly reduces memory usage for large language models. Memory chipmakers could face pressure, but investors may be worrying too much. This industry, and one ...
French AI startup Mistral has secured $830 million in debt financing. The funds will go towards operating a data center near Paris. The announcement comes as Mistral increasingly invests in building ...
Few evils are as demoralizing or debilitating as the toxic “air of inevitability,” a creeping sense that some fights — no matter how righteous — just can’t be won. The grim history of our valley’s ...
The data were also used to develop a normative model, a statistical framework for understanding atypical biological features by comparing an individual to a reference population, and a data-clustering ...
TikTok's US app has been glitchy for days as it faces issues tied to a Oracle data center outage. Users have reported seeing a flurry of old videos in their feeds and 0 views on new uploads. The ...
Meta has cut a trio of deals to power its artificial intelligence data centers, securing enough energy to light up the equivalent of about 5 million homes. The parent company of Facebook on Friday ...
I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
One day in November, a product strategist we’ll call Michelle (not her real name), logged into her LinkedIn account and switched her gender to male. She also changed her name to Michael, she told ...
Impressive results of a potential second-line combination treatment for multiple myeloma from the Majestec-3 trial of teclistamab plus daratumumab raised eyebrows at the American Society of Hematology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results